{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:21:38Z","timestamp":1762176098766},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1994,11,1]],"date-time":"1994-11-01T00:00:00Z","timestamp":783648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gen Intern Med"],"published-print":{"date-parts":[[1994,11]]},"DOI":"10.1007\/bf02600301","type":"journal-article","created":{"date-parts":[[2007,4,4]],"date-time":"2007-04-04T00:57:28Z","timestamp":1175648248000},"page":"599-605","source":"Crossref","is-referenced-by-count":26,"title":["Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction"],"prefix":"10.1007","volume":"9","author":[{"given":"Shahid H.","family":"Sial","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean L","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Battiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Nachodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02600301_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archinte.1993.00410030005001","volume":"153","author":"PC Deedwania","year":"1993","unstructured":"Deedwania PC, Carbajal EV. Secondary prevention after myocardial infarction. Too many choices, which ones work? [editorial]. Arch Intern Med. 1993;153:285\u20138.","journal-title":"Arch Intern Med"},{"key":"BF02600301_CR2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","volume":"260","author":"S Yusuf","year":"1988","unstructured":"Yusuf S, Wittes, J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA. 1988;260:2088\u201393.","journal-title":"JAMA"},{"key":"BF02600301_CR3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","volume":"27","author":"S Yusuf","year":"1985","unstructured":"Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335\u201371.","journal-title":"Prog Cardiovasc Dis"},{"key":"BF02600301_CR4","first-page":"31","volume-title":"Beta-Blockers and Cardiac Arrhythmias","author":"JL Anderson","year":"1992","unstructured":"Anderson JL. Effects of beta-blocker on ventricular fibrillation threshold. In: Deedwania PC (ed). Beta-Blockers and Cardiac Arrhythmias. New York: Marcel Dekker, 1992;31\u201353."},{"key":"BF02600301_CR5","first-page":"133","volume-title":"Beta-Blockers and Cardiac Arrhythmias","author":"E Lichstein","year":"1992","unstructured":"Lichstein E. Effects of beta-blockers on cardiac arrhythmia in acute myocardial infarction: the BHAT experience. In: Deedwania P (ed). Beta-Blockers and Cardiac Arrhythmias. New York: Marcel Dekker, 1992;133\u201349."},{"key":"BF02600301_CR6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0735-1097(10)80322-5","volume":"16","author":"SC Smith Jr","year":"1990","unstructured":"Smith SC Jr, Gilpin E, Ahnve S, et al. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol. 1990;16:784\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"BF02600301_CR7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9149(91)90397-4","volume":"68","author":"TJ Montague","year":"1991","unstructured":"Montague TJ, Ikuta RM, Wong Ry, Bay KS, Teo KK, Davies NJ. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two year period (1987\u20131989). Am J Cardiol. 1991;68:843\u20137.","journal-title":"Am J Cardiol"},{"key":"BF02600301_CR8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9343(92)90192-E","volume":"93","author":"JH Gurwitz","year":"1992","unstructured":"Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alper JS. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med. 1992;93:605\u201310.","journal-title":"Am J Med"},{"key":"BF02600301_CR9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"32","author":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","unstructured":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;32:406\u201312.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archinte.1992.00400170062012","volume":"152","author":"C Maynard","year":"1992","unstructured":"Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med. 1992;152:972\u20136.","journal-title":"Arch Intern Med"},{"key":"BF02600301_CR11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-116-10-785","volume":"116","author":"HM Krumholz","year":"1992","unstructured":"Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med. 1992;116:785\u201390.","journal-title":"Ann Intern Med"},{"key":"BF02600301_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-107-1-19","volume":"107","author":"JN Tobin","year":"1987","unstructured":"Tobin JN, Wessertheir-Smoller S, Wexler JP, et al. Sex bias in considering coronary bypass surgery. Ann Intern Med. 1987;107:19\u201325.","journal-title":"Ann Intern Med"},{"key":"BF02600301_CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJM199107253250401","volume":"325","author":"JZ Ayanian","year":"1991","unstructured":"Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325:221\u20135.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archinte.1993.00410050061008","volume":"153","author":"P Pagley","year":"1993","unstructured":"Pagley P, Yanzebski J, Goldberg R, et al. Gender differences in the treatment of patients with acute myocardial infarction. A multi-hospital community-based perspective. Arch Intern Med. 1993;153:625\u20139.","journal-title":"Arch Intern Med"},{"key":"BF02600301_CR15","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1001\/jama.1993.03500200056033","volume":"269","author":"JZ Ayanian","year":"1993","unstructured":"Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. JAMA. 1993;269:2642\u20136.","journal-title":"JAMA"},{"key":"BF02600301_CR16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-118-8-199304150-00004","volume":"118","author":"P Johnson","year":"1993","unstructured":"Johnson P, Lee TH, Cook EF, Rouan GW, Goldman L. Effect of race on the presentation and management of patients with acute chest pain. Ann Intern Med. 1993;118:593\u2013601.","journal-title":"Ann Intern Med"},{"key":"BF02600301_CR17","first-page":"288","volume-title":"Cecil Texbook of Medicine","author":"JT Willerson","year":"1985","unstructured":"Willerson JT. Acute myocardial infarction. In: Wyngaarden J, Smith LH Jr (eds). Cecil Texbook of Medicine, 17th ed. Philadelphia: W. B. Saunders, Company, 1985;288.","edition":"17th ed."},{"key":"BF02600301_CR18","first-page":"498","volume-title":"Merck Manual of Diagnosis and Therapy","year":"1987","unstructured":"Diseases of the heart and pericardium. In: Berkow R, Fletcher AJ (eds). Merck Manual of Diagnosis and Therapy. Rahway, NJ: Merck Sharp and Dohme Research Laboratories, 1987;498."},{"key":"BF02600301_CR19","first-page":"987","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"R Pasternak","year":"1987","unstructured":"Pasternak R, Braunwald E, Alpert J. Acute myocardial infarction. In: Braunwald E, Isselbacher K, Petersdorf R, Wilson J, Martin J, Fauci A (eds). Harrison\u2019s Principles of Internal Medicine, 11th ed. New York: McGraw-Hill, 1987;987.","edition":"11th ed."},{"key":"BF02600301_CR20","first-page":"235","volume-title":"Current Medical Diagnosis and Treatment","author":"M Sokolow","year":"1989","unstructured":"Sokolow M, Massie B. Heart and great vessels. In: Schroeder SA, Krupp M, Trerney L, McPhee SJ (eds). Current Medical Diagnosis and Treatment. East Norwalk, CT: Appleton and Lange, 1989;235\u20136."},{"key":"BF02600301_CR21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","volume":"247","author":"Beta-Blocker Therapy Heart Attack Trial Research Group","year":"1982","unstructured":"Beta-Blocker Therapy Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982;247:1707-l4.","journal-title":"JAMA"},{"key":"BF02600301_CR22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM198104023041401","volume":"304","author":"The Norwegian Multicenter Study Group","year":"1981","unstructured":"The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801\u20137.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","volume":"2","author":"A Hjalmanson","year":"1981","unstructured":"Hjalmanson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomized trial. Lancet. 1981;2:823\u20137.","journal-title":"Lancet"},{"key":"BF02600301_CR24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(79)92684-9","volume":"2","author":"MP Anderson","year":"1979","unstructured":"Anderson MP, Bechsgaard P, Frederiksen J, et al. Effect of alprenolol in mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. Lancet. 1979;2:865\u20138.","journal-title":"Lancet"},{"key":"BF02600301_CR25","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1001\/jama.1991.03470230058031","volume":"266","author":"PA Braveman","year":"1991","unstructured":"Braveman PA, Egerter S, Bennett T, Showstack J. Differences in hospital resource allocation among sick newborns according to insurance coverage. JAMA. 1991;266:3300\u20138.","journal-title":"JAMA"},{"key":"BF02600301_CR26","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1001\/jama.1989.03420240086032","volume":"261","author":"J Weissman","year":"1989","unstructured":"Weissman J, Epstein AM. Case mix and resource utilization by uninsured hospital patients in the Boston metropolitan area. JAMA. 1989;261:3572\u20136.","journal-title":"JAMA"},{"key":"BF02600301_CR27","first-page":"457","volume":"29","author":"BC Spillman","year":"1992","unstructured":"Spillman BC. The impact of being uninsured on utilization of basic health care services. Inquiry. 1992;29:457\u201366.","journal-title":"Inquiry"},{"key":"BF02600301_CR28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1377\/hlthaff.6.1.6","volume":"6","author":"HE Freeman","year":"1987","unstructured":"Freeman HE, Blendon RJ, Aiken LH, Sudman S, Mullinix CF, Corey CR. Health Aff. 1987;6:6\u201318.","journal-title":"Health Aff"},{"key":"BF02600301_CR29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.1990.03450100045023","volume":"264","author":"MB Wenneker","year":"1990","unstructured":"Wenneker MB, Weissman JS, Epstein AM. The association of payer with utilization of cardiac procedures in Massachusetts. JAMA. 1990;264:1255\u201360.","journal-title":"JAMA"},{"key":"BF02600301_CR30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJM198803103181006","volume":"318","author":"ER Greenberg","year":"1988","unstructured":"Greenberg ER, Chute CG, Stukel T, et al. N Engl J Med. 1988;318:612\u20137.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jama.1993.03500060087037","volume":"269","author":"C Hafner-Eaton","year":"1993","unstructured":"Hafner-Eaton C. Physician utilization disparities between the uninsured and insured. JAMA. 1993;269:787\u201392.","journal-title":"JAMA"},{"key":"BF02600301_CR32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2105\/AJPH.74.12.1331","volume":"74","author":"LA Aday","year":"1984","unstructured":"Aday LA, Andersen RM. The national profile of access to medical care: where do we stand? Am J Public Health. 1984;74:1331\u20139.","journal-title":"Am J Public Health"},{"key":"BF02600301_CR33","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1001\/jama.1988.03720190040028","volume":"259","author":"S Woolhandler","year":"1988","unstructured":"Woolhandler S, Himmelstein DU. Reverse targeting of preventive care due to lack of health insurance. JAMA. 1988;259:2872\u20134.","journal-title":"JAMA"},{"key":"BF02600301_CR34","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archinte.1988.00380050181026","volume":"148","author":"RA Hayward","year":"1988","unstructured":"Hayward RA, Shapiro MF, Freeman HE, Corey CR. Who gets screened for cervical and breast cancer? Arch Intern Med. 1988;148:1177\u201381.","journal-title":"Arch Intern Med"},{"key":"BF02600301_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/oxfordjournals.eurheartj.a059591","volume":"11","author":"J Kjekshus","year":"1990","unstructured":"Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, and Ross J Jr. Diabetic patients and beta blockers after acute myocardial infarction. Eur Heart J. 1990;11:43\u201350.","journal-title":"Eur Heart J"},{"key":"BF02600301_CR36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.1991.00400090063012","volume":"151","author":"K Radack","year":"1991","unstructured":"Radack K, Deck C. \u03b2-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. Arch Intern Med. 1991;151:1769\u201376.","journal-title":"Arch Intern Med"},{"key":"BF02600301_CR37","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.68.6.1280","volume":"68","author":"DL Johnston","year":"1983","unstructured":"Johnston DL, Gebhardt VA, Donald A, Kostuk WJ. Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventriculography. Circulation. 1983;68:1280\u20139.","journal-title":"Circulation"},{"key":"BF02600301_CR38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"M Pfeffer","year":"1992","unstructured":"Pfeffer M, Braunwald E, Moye L, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669\u201377.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"J Nicklas","year":"1992","unstructured":"Nicklas J, Pitt B, Rogers W, et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685\u201391.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","volume":"319","author":"The Multicenter Diltiazem Postinfarction Trial Research Group","year":"1988","unstructured":"The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988;319:385\u201392.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/oxfordjournals.eurheartj.a062511","volume":"9","author":"The Israeli SPRINT","year":"1988","unstructured":"The Israeli SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT): a randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J. 1988;9:354\u201364.","journal-title":"Eur Heart J"},{"key":"BF02600301_CR42","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bmj.293.6556.1204","volume":"293","author":"R Wilcox","year":"1986","unstructured":"Wilcox R, Hampton J, Banks D, et al. Trial of early nifedipine in acute myocardial infarction: the TRENT Study. Br Med J. 1986;293:1204\u20138.","journal-title":"Br Med J"},{"issue":"suppl 6","key":"BF02600301_CR43","first-page":"IV107","volume":"80","author":"R Gibson","year":"1989","unstructured":"Gibson R. Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction. Circulation. 1989;80(suppl 6):IV107-IV119.","journal-title":"Circulation"},{"key":"BF02600301_CR44","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/01.CIR.69.4.740","volume":"69","author":"JE Muller","year":"1984","unstructured":"Muller JE, Morrison J, Stone PH, et al. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation. 1984;69:740\u20137.","journal-title":"Circulation"},{"key":"BF02600301_CR45","first-page":"987","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"RC Pasternak","year":"1987","unstructured":"Pasternak RC, Braunwald E. Acute myocardial infarction. In: Wilson JD, Braunwald E, Isselbacher KJ, et al. (eds). Harrison\u2019s Principles of Internal Medicine, 12 ed. New York: McGraw-Hill, 1987;987.","edition":"12 ed."},{"key":"BF02600301_CR46","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1001\/jama.1992.03480130099032","volume":"267","author":"R Brigut","year":"1992","unstructured":"Brigut R, Everitt DE. Beta-blockers and depression. Evidence against an association. JAMA. 1992;267:1783\u20137.","journal-title":"JAMA"},{"key":"BF02600301_CR47","first-page":"163","volume":"6","author":"RS Rosenson","year":"1993","unstructured":"Rosenson RS. The truth about beta blocker adverse effects\u2014depression, claudication, and lipids. J Ambul Monit. 1993;6:163\u201371.","journal-title":"J Ambul Monit"},{"issue":"suppl 7","key":"BF02600301_CR48","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/00005344-198906147-00007","volume":"14","author":"R Fogari","year":"1989","unstructured":"Fogari R, Zoppi A, Pasotti C, et al. Plasma lipids during chronic anti-hypertensive therapy with different \u03b2-blockers. J Cardiovasc Pharmacol. 1989;14(suppl 7):S28-S32.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02600301_CR49","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM199310213291714","volume":"329","author":"PJ Greco","year":"1993","unstructured":"Greco PJ, Eisenberg JM. Changing physicians\u2019 practices. N Engl J Med 1993;329:1271\u20133.","journal-title":"N Engl J Med"},{"key":"BF02600301_CR50","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1136\/bmj.284.6331.1749","volume":"284","author":"NS Baber","year":"1982","unstructured":"Baber NS, Lewis JA. Confidence in results of beta blocker postinfarction trials. Br Med J. 1982;284:1749\u201350.","journal-title":"Br Med J"},{"key":"BF02600301_CR51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jama.1992.03490020088036","volume":"268","author":"EM Antman","year":"1992","unstructured":"Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992;268:240\u20138.","journal-title":"JAMA"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02600301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02600301\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02600301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T14:33:09Z","timestamp":1558189989000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02600301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1994,11]]}},"alternative-id":["BF02600301"],"URL":"https:\/\/doi.org\/10.1007\/bf02600301","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,11]]}}}